000448 UTILIZABILITY OF THE SERUM IGF-1, IGFBP-3, LEPTIN AND CA-125 LEVELS IN BENIGN-MALIGN DIFFERENTIATION IN PATIENTS WITH OVARIAN TUMORS | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Poster Group 3B – Wednesday, September 28, 2005

000448 UTILIZABILITY OF THE SERUM IGF-1, IGFBP-3, LEPTIN AND CA-125 LEVELS IN BENIGN-MALIGN DIFFERENTIATION IN PATIENTS WITH OVARIAN TUMORS

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Serin IS, Yilmaz MO, Ozcelik B, et al

000448 UTILIZABILITY OF THE SERUM IGF-1, IGFBP-3, LEPTIN AND CA-125 LEVELS IN BENIGN-MALIGN DIFFERENTIATION IN PATIENTS WITH OVARIAN TUMORS

International Journal of Gynecologic Cancer 2005;15:175.